Australia TGA ARTG recordDermaV - Dermatological Nd:YAG laser system
Australia TGA ARTG Registered Device · Ebos Medical Devices Australia Pty Ltd · Lutronic Corporation · Class IIb · Started November 07, 2023
Good Name: Ebos Medical Devices Australia Pty Ltd - DermaV - Dermatological Nd:YAG laser system
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- November 07, 2023
- Effective Date
- November 07, 2023
- Country
- South Korea
- Address
- Lutronic Center 219 Sowon-ro Deogyang-gu, Goyang-si, Gyeonggi-do
DermaV is intended for use in the medical specialty of dermatology requiring selective photothermolysis of target chromophores in soft tissue. The 532 nm wavelength is intended to be used by a trained physician as treatment of the following: -Benign vascular lesions, including Spider veins of the lower extremities - Benign cutaneous lesions, including Erythematous scars The 1064 nm wavelength is intended to be used by a trained physician as treatment of the following: - Benign vascular lesions, including Port wine stains
Access comprehensive regulatory information for DermaV - Dermatological Nd:YAG laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Ebos Medical Devices Australia Pty Ltd, manufactured by Lutronic Corporation in South Korea. The device registration started on November 07, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.